Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Pradeep ThapaSandip Basu

Abstract

This prospective study compared 177Lu-ethylene diamine tetramethylene phosphonate (EDTMP) with 153Sm-EDTMP for painful skeletal metastases. Half of the 32 patients were treated with 177Lu-EDTMP and half with 153Sm-EDTMP, at 37 MBq/kg of body weight. Analgesic, pain, and quality-of-life scores (EORTC, Karnofsky, ECOG) and bone proliferation marker were used to examine efficacy. Hematologic toxicity was evaluated using NCI-CTCAE and compared between groups at baseline and each month till 3 mo after therapy. Pain relief was categorized as complete, partial, minimal, or none. Pain relief with 177Lu-EDTMP was 80%: 50% complete, 41.67% partial, and 8.33% minimal. Pain relief with 153Sm-EDTMP was 75%: 33.33% complete, 58.33% partial, and 8.33% minimal. The difference was not significant (P=1.000). Quality of life at 3 mo after therapy improved significantly in both groups as per ECOG score (P=0.014 and 0.005 for 177Lu-EDTMP and 153Sm-EDTMP, respectively), Karnofsky index (P=0.007 and 0.023 for 177Lu-EDTMP and 153Sm-EDTMP, respectively), and EORTC score (P=0.004 and <0.001 for 177Lu-EDTMP and 153Sm-EDTMP, respectively). Bone proliferation marker in responders of both groups dropped significantly (P=0.008 for 177Lu-EDTMP and P=0.019 for...Continue Reading

References

Mar 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·D P DearnaleyV J Lewington
Mar 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O S NielsenI F Tannock
Jan 1, 1989·European Journal of Nuclear Medicine·J H TurnerP G Claringbold
Apr 1, 1983·Urology·S C Jacobs
Dec 1, 1994·International Journal of Radiation Oncology, Biology, Physics·A N Serafini
Nov 1, 1995·Pain·P J Hoskin
Apr 1, 1997·Seminars in Nuclear Medicine·A J McEwan
Dec 9, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I RescheD Wilkins
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A N SerafiniK A Harrison
Mar 23, 2000·Seminars in Radiation Oncology·A J McEwan
Jun 22, 2001·Cancer Treatment Reviews·P Garnero
Dec 19, 2001·Nuclear Medicine Communications·S ChakrabortyM R A Pillai
Aug 2, 2002·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Tapas DasM R A Pillai
Jun 1, 2005·The Lancet Oncology·Ilora G FinlayMike Shelley
May 6, 2008·Cancer Biotherapy & Radiopharmaceuticals·Sudipta ChakrabortyMaroor R A Pillai
Jul 24, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Lisa BodeiUNKNOWN European Association of Nuclear Medicine (EANM)
Jul 30, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Krishan Kant AgarwalChandrasekhar Bal

❮ Previous
Next ❯

Citations

Apr 29, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Luigia FlorimonteLorenzo Stefano Maffioli
Nov 15, 2018·Journal of Labelled Compounds & Radiopharmaceuticals·Qin XuYue Chen
Jan 22, 2019·Journal of Labelled Compounds & Radiopharmaceuticals·K V VimalnathSudipta Chakraborty
Apr 13, 2019·Cancer Biotherapy & Radiopharmaceuticals·Mehrosadat AlaviMohammad Ghannadi-Maragheh
Oct 18, 2016·Clinical Nuclear Medicine·Tapas DasSharmila Banerjee
Jan 3, 2018·The British Journal of Radiology·Ana M Denis-BacelarGlenn D Flux
Sep 19, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hélène Kolesnikov-GauthierNicolas Penel
Nov 30, 2018·Asia-Pacific Journal of Clinical Oncology·Junpei Iizuka
Jul 5, 2019·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Pradeep Thapa, Sandip Basu
Aug 19, 2020·Journal of Clinical Medicine·Reyhaneh Manafi-FaridMohsen Beheshti
Dec 2, 2020·Cancer Biotherapy & Radiopharmaceuticals·Emran AskariRamin Sadeghi
Jun 1, 2021·PET Clinics·Nasim VahidfarHojjat Ahmadzadehfar
Jan 10, 2021·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·René FernándezHoracio Amaral
Apr 15, 2021·Nuclear Medicine Communications·Neeraja BollampallyAshutosh K Dash
Oct 14, 2021·Thyroid : Official Journal of the American Thyroid Association·Sanjana BallalChandrasekhar Bal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.